Format

Send to

Choose Destination
See comment in PubMed Commons below
Expert Opin Investig Drugs. 2001 Feb;10(2):321-9.

Granulysin: a novel antimicrobial.

Author information

1
Department of Medicine, Division of Nephrology, Stanford University, Stanford, CA 94305, USA.

Abstract

Granulysin is a novel lytic molecule produced by human cytolytic T-lymphocytes (CTLs) and natural killer (NK) cells. It is active against a broad range of microbes, including Gram-positive and -negative bacteria, parasites and Mycobacterium tuberculosis. It is functionally related to other antibacterial peptides, like defensins and magainins, but is structurally distinct. It has structural similarity to porcine NK-lysin and to amoebapores made by Entamoeba histolytica. Synthetic peptides derived from granulysin have differential activity against eukaryotic cells and bacteria. Selective bactericidal peptides may have therapeutic roles as novel antibiotics.

PMID:
11178344
DOI:
10.1517/13543784.10.2.321
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center